Rothschild Investment LLC Cassava Sciences Inc Call Options Transaction History
Rothschild Investment LLC
- $1.53 Trillion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding SAVA
# of Institutions
197Shares Held
13.7MCall Options Held
1.5MPut Options Held
2.33M-
Black Rock Inc. New York, NY3.22MShares$84.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.52MShares$66.6 Million0.0% of portfolio
-
State Street Corp Boston, MA1.18MShares$31 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.01MShares$26.6 Million0.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA691KShares$18.2 Million0.0% of portfolio
About CASSAVA SCIENCES INC
- Ticker SAVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,097,900
- Market Cap $1.06B
- Description
- Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...